Dandra Parker serves as the Director of Medical Science Liaison (MSL) for Neurology at Novartis, where she leverages her extensive expertise in biochemistry and physiology to drive innovative approaches in the field of neuroscience. With a robust background in both qualitative research and animal models,...
Dandra Parker serves as the Director of Medical Science Liaison (MSL) for Neurology at Novartis, where she leverages her extensive expertise in biochemistry and physiology to drive innovative approaches in the field of neuroscience. With a robust background in both qualitative research and animal models, Dandra is adept at translating complex scientific concepts into actionable insights that enhance patient care and inform clinical strategies. Her commitment to advancing neurology is underscored by her impressive accolades, including the prestigious 2023 Neuroscience Field Medical Lighthouse Award, which recognizes her exceptional leadership and peer influence within the field.
In her current role, Dandra is pivotal in spearheading key projects that align with Novartis's mission to deliver transformative therapies for neurological disorders. She has played a crucial role in the successful launch of groundbreaking treatments, earning the 2021 President's Award for Launch Excellence and being named MSL of the Year for her outstanding performance during this critical period. Her ability to foster collaborative relationships with healthcare professionals and stakeholders is a testament to her dedication to Novartis's values, which earned her the 2022 Values in Action Award.
Dandra's recent professional development, including certifications in Team and Business Leadership, further enhances her capacity to lead cross-functional teams effectively. Her skills in presentations and university teaching allow her to communicate complex scientific data clearly and engagingly, ensuring that both internal teams and external partners are aligned in their understanding of the latest advancements in neurology. With a passion for driving scientific innovation and a commitment to excellence, Dandra Parker continues to make significant contributions to the field of neurology at Novartis.
